NCT06505590
- Conditions
- Cancer Diagnosis, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Gustave Roussy Villejuif, France
Clinical trial condition
Lymphoma, Follicular
Explore clinical trials studying Lymphoma, Follicular. Study availability and eligibility vary by location and protocol.
1,362 public trials
202 recruiting studies
Lymphoma, Follicular trial results
Recruiting
Hypnosis: a Path to Appeasement
NCT05942885
- Conditions
- Anxiety Disorders, Hematologic Cancer, Hematologic Diseases, +15 more
- Locations
-
- Service MB1 - Hôpital Lyon Sud - HCL Lyon, Pierre-Bénite, France
NCT06691698
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +16 more
- Locations
-
- Region Skåne Kristianstad, Skåne County, Sweden
- Region Värmland Karlstad, Värmland County, Sweden
NCT06292741
- Conditions
- Brain Diseases, Central Nervous System Diseases, Dementia, +15 more
- Locations
-
- Clinica della memria- Fondazione Policlinico Agostino Gemelli IRCCS Rome, Lazio, Italy
NCT07126678
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Jiangsu Province Hospital Nanjing, Jiangsu, China
Recruiting
HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL
NCT06792825
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Masonic Cancer Center Minneapolis, Minnesota, United States
NCT02393157
- Conditions
- Burkitt Lymphoma, CD20+ Lymphoblastic Lymphoma, DNA Virus Infections, +21 more
- Locations
-
- New York Medical College Valhalla, New York, United States
Recruiting
AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
NCT06340737
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +38 more
- Locations
-
- Stanford University Palo Alto, California, United States
NCT06213636
- Conditions
- Acute Lymphoblastic Leukemia, Adult B-Cell, Acute Lymphoblastic Leukemia, in Relapse, Central Nervous System Lymphoma, +19 more
- Locations
-
- District One Hospital Beijing, Beijing Municipality, China
Recruiting
A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies
NCT06045910
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
- Locations
-
- University Hospital Birmingham NHS Foundation Trust Birmingham, United Kingdom
- Cambridge University Hospitals Cambridge, United Kingdom
- St James's University Hospital Leeds, United Kingdom
- University Hospital London Hospital London, United Kingdom